{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:49:42Z","timestamp":1787068182845,"version":"build-2736575974"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100031478","name":"Next Generation EU","doi-asserted-by":"crossref","award":["PE0000015"],"award-info":[{"award-number":["PE0000015"]}],"id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Geriatr Med"],"DOI":"10.1007\/s41999-025-01269-x","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T10:00:03Z","timestamp":1752141603000},"page":"1933-1949","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["What\u2019s behind delirium: is there a specific role for medications?"],"prefix":"10.1007","volume":"16","author":[{"given":"Alessia","family":"Beccacece","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olafur","family":"Samuelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freyja","family":"J\u00f3nsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0130-5805","authenticated-orcid":false,"given":"Massimiliano","family":"Fedecostante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adalsteinn","family":"Gudmundsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cherubini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"1269_CR1","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3390\/healthcare10081544","volume":"10","author":"K Komici","year":"2022","unstructured":"Komici K, Guerra G, Addona F, Fantini C (2022) Delirium in nursing home residents: a narrative review. Healthcare 10:1544. https:\/\/doi.org\/10.3390\/healthcare10081544","journal-title":"Healthcare"},{"key":"1269_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/gps.3814","volume":"28","author":"E De Lange","year":"2013","unstructured":"De Lange E, Verhaak PFM, Van Der Meer K (2013) Prevalence, presentation and prognosis of delirium in older people in the population, at home and in long term care: a review. Int J Geriat Psychiatry 28:127\u2013134. https:\/\/doi.org\/10.1002\/gps.3814","journal-title":"Int J Geriat Psychiatry"},{"key":"1269_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-024-01861-4","author":"AE Weidmann","year":"2025","unstructured":"Weidmann AE, Propp\u00e9 GB, Matth\u00edasd\u00f3ttir R, Tadi\u0107 I, Gunnarsson PS, J\u00f3nsd\u00f3ttir F (2025) Medication-induced causes of delirium in patients with and without dementia: a systematic review of published neurology guidelines. Int J Clin Pharm. https:\/\/doi.org\/10.1007\/s11096-024-01861-4","journal-title":"Int J Clin Pharm"},{"key":"1269_CR4","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1111\/jgs.18896","volume":"72","author":"A Cherubini","year":"2024","unstructured":"Cherubini A, Denkinger M, Knol W, Gudmundsson A (2024) How to improve drug evaluation in older patients: The perspective of the European Geriatric Medicine Society ( EuGMS ). J Am Geriatr Soc 72:2928\u20132932. https:\/\/doi.org\/10.1111\/jgs.18896","journal-title":"J Am Geriatr Soc"},{"key":"1269_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s41999-023-00924-5","volume":"15","author":"W Wieczorek-Stawi\u0144ska","year":"2024","unstructured":"Wieczorek-Stawi\u0144ska W, Ry\u015b M, Perera I, Rudzi\u0144ska A, Gryglewska B, G\u0105sowski J et al (2024) Delirium is not dementia: delirium awareness day-related event at the University Hospital in Krakow. Eur Geriatr Med 15:407\u2013410. https:\/\/doi.org\/10.1007\/s41999-023-00924-5","journal-title":"Eur Geriatr Med"},{"key":"1269_CR6","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s41999-024-01019-5","volume":"15","author":"AM Ornago","year":"2024","unstructured":"Ornago AM, Pinardi E, Okoye C, Mazzola P, Ferrara MC, Finazzi A et al (2024) Delirium prevalence and delirium literacy across Italian hospital wards: a secondary analysis of data from the World Delirium Awareness Day 2023. Eur Geriatr Med 15:1405\u20131413. https:\/\/doi.org\/10.1007\/s41999-024-01019-5","journal-title":"Eur Geriatr Med"},{"key":"1269_CR7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12877-020-01745-y","volume":"20","author":"AF Fog","year":"2020","unstructured":"Fog AF, Mdala I, Engedal K, Straand J (2020) Variation between nursing homes in drug use and in drug-related problems. BMC Geriatr 20:336. https:\/\/doi.org\/10.1186\/s12877-020-01745-y","journal-title":"BMC Geriatr"},{"key":"1269_CR8","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/j.1532-5415.1997.tb02964.x","volume":"45","author":"JT Hanlon","year":"1997","unstructured":"Hanlon JT, Schmader KE, Koronkowski MJ, Weinberger M, Landsman PB, Samsa GP et al (1997) Adverse drug events in high risk older outpatients. J Am Geriatr Soc 45:945\u2013948. https:\/\/doi.org\/10.1111\/j.1532-5415.1997.tb02964.x","journal-title":"J Am Geriatr Soc"},{"key":"1269_CR9","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S1474-4422(15)00101-5","volume":"14","author":"TG Fong","year":"2015","unstructured":"Fong TG, Davis D, Growdon ME, Albuquerque A, Inouye SK (2015) The interface between delirium and dementia in elderly adults. The Lancet Neurol 14:823\u2013832. https:\/\/doi.org\/10.1016\/S1474-4422(15)00101-5","journal-title":"The Lancet Neurol"},{"key":"1269_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/acps.13505","volume":"147","author":"M Reisinger","year":"2023","unstructured":"Reisinger M, Reininghaus EZ, Biasi JD, Fellendorf FT, Schoberer D (2023) Delirium-associated medication in people at risk: a systematic update review, meta-analyses, and GRADE -profiles. Acta Psychiatr Scand 147:16\u201342. https:\/\/doi.org\/10.1111\/acps.13505","journal-title":"Acta Psychiatr Scand"},{"key":"1269_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jamda.2023.08.019","volume":"25","author":"C Webber","year":"2024","unstructured":"Webber C, Milani C, Bjerre LM, Lawlor PG, Bush SH, Watt CL et al (2024) Potentially inappropriate prescribing in long-term care and its relationship with probable delirium. J Am Med Dir Assoc 25:130-137.e4. https:\/\/doi.org\/10.1016\/j.jamda.2023.08.019","journal-title":"J Am Med Dir Assoc"},{"key":"1269_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012759","volume":"7","author":"I Abraha","year":"2017","unstructured":"Abraha I, Rimland JM, Trotta FM, Dell\u2019Aquila G, Cruz-Jentoft A, Petrovic M et al (2017) Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series BMJ Open 7:e012759. https:\/\/doi.org\/10.1136\/bmjopen-2016-012759","journal-title":"The SENATOR-OnTop series BMJ Open"},{"key":"1269_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.dadm.2016.11.002","volume":"7","author":"E Sepulveda","year":"2017","unstructured":"Sepulveda E, Leonard M, Franco JG, Adamis D, McCarthy G, Dunne C et al (2017) Subsyndromal delirium compared with delirium, dementia, and subjects without delirium or dementia in elderly general hospital admissions and nursing home residents. Alz Dem Diag Ass Dis Mo 7:1\u201310. https:\/\/doi.org\/10.1016\/j.dadm.2016.11.002","journal-title":"Alz Dem Diag Ass Dis Mo"},{"key":"1269_CR14","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","volume":"394","author":"EO Hoogendijk","year":"2019","unstructured":"Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP (2019) Frailty: implications for clinical practice and public health. The Lancet 394:1365\u20131375. https:\/\/doi.org\/10.1016\/S0140-6736(19)31786-6","journal-title":"The Lancet"},{"key":"1269_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s41999-018-0124-5","volume":"10","author":"K Palmer","year":"2019","unstructured":"Palmer K, Villani ER, Vetrano DL, Cherubini A, Cruz-Jentoft AJ, On behalf of the European Geriatric Medicine Society Pharmacology special interest group et al (2019) Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis. Eur Geriatr Med 10:9\u201336. https:\/\/doi.org\/10.1007\/s41999-018-0124-5","journal-title":"Eur Geriatr Med"},{"key":"1269_CR16","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/ageing\/afab042","volume":"50","author":"P Mazzola","year":"2021","unstructured":"Mazzola P, Tassistro E, Di Santo S, Rossi E, Andreano A, Valsecchi MG et al (2021) The relationship between frailty and delirium: insights from the 2017 Delirium Day study. Age Ageing 50:1593\u20131599. https:\/\/doi.org\/10.1093\/ageing\/afab042","journal-title":"Age Ageing"},{"key":"1269_CR17","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/ageing\/afab003","volume":"50","author":"SN Hilmer","year":"2021","unstructured":"Hilmer SN, Kirkpatrick CMJ (2021) New Horizons in the impact of frailty on pharmacokinetics: latest developments. Age Ageing 50:1054\u20131063. https:\/\/doi.org\/10.1093\/ageing\/afab003","journal-title":"Age Ageing"},{"key":"1269_CR18","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.jamda.2021.03.019","volume":"22","author":"P Anrys","year":"2021","unstructured":"Anrys P, Petit A-E, Thevelin S, Sallevelt B, Drenth C, Soiza RL et al (2021) An international consensus list of potentially clinically significant drug-drug interactions in older people. J Am Med Dir Assoc 22:2121-2133.e24. https:\/\/doi.org\/10.1016\/j.jamda.2021.03.019","journal-title":"J Am Med Dir Assoc"},{"key":"1269_CR19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40266-015-0333-2","volume":"33","author":"M D\u00f6rks","year":"2016","unstructured":"D\u00f6rks M, Herget-Rosenthal S, Schmiemann G, Hoffmann F (2016) Polypharmacy and renal failure in nursing home residents: results of the inappropriate medication in patients with renal insufficiency in nursing homes (IMREN) study. Drugs Aging 33:45\u201351. https:\/\/doi.org\/10.1007\/s40266-015-0333-2","journal-title":"Drugs Aging"},{"key":"1269_CR20","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1111\/bcp.14094","volume":"86","author":"AC Drenth-van Maanen","year":"2020","unstructured":"Drenth-van Maanen AC, Wilting I, Jansen PAF (2020) Prescribing medicines to older people\u2014How to consider the impact of ageing on human organ and body functions. Brit J Clinical Pharma 86:1921\u20131930. https:\/\/doi.org\/10.1111\/bcp.14094","journal-title":"Brit J Clinical Pharma"},{"key":"1269_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/17512433.2020.1697676","volume":"13","author":"D O\u2019Mahony","year":"2020","unstructured":"O\u2019Mahony D (2020) STOPP\/START criteria for potentially inappropriate medications\/potential prescribing omissions in older people: origin and progress. Expert Rev Clin Pharmacol 13:15\u201322. https:\/\/doi.org\/10.1080\/17512433.2020.1697676","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1269_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE (2017) What is polypharmacy? A systematic review of definitions. BMC Geriatr 17:230. https:\/\/doi.org\/10.1186\/s12877-017-0621-2","journal-title":"BMC Geriatr"},{"key":"1269_CR23","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1001\/archinte.161.13.1629","volume":"161","author":"TS Field","year":"2001","unstructured":"Field TS, Gurwitz JH, Avorn J, McCormick D, Jain S, Eckler M et al (2001) Risk factors for adverse drug events among nursing home residents. Arch Intern Med 161:1629. https:\/\/doi.org\/10.1001\/archinte.161.13.1629","journal-title":"Arch Intern Med"},{"key":"1269_CR24","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s40520-018-0893-1","volume":"30","author":"G Onder","year":"2018","unstructured":"Onder G, Giovannini S, Sganga F, Manes-Gravina E, Topinkova E, Finne-Soveri H et al (2018) Interactions between drugs and geriatric syndromes in nursing home and home care: results from Shelter and IBenC projects. Aging Clin Exp Res 30:1015\u20131021. https:\/\/doi.org\/10.1007\/s40520-018-0893-1","journal-title":"Aging Clin Exp Res"},{"key":"1269_CR25","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/ageing\/afaa159","volume":"50","author":"D Curtin","year":"2021","unstructured":"Curtin D, Gallagher P, O\u2019Mahony D (2021) Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2. Age Ageing 50:465\u2013471. https:\/\/doi.org\/10.1093\/ageing\/afaa159","journal-title":"Age Ageing"},{"key":"1269_CR26","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1186\/s12877-024-05450-y","volume":"24","author":"A Malek Makan","year":"2024","unstructured":"Malek Makan A, Van Hout H, Onder G, Finne-Soveri H, Fialova D, Van Marum R (2024) Prevalence of potentially inappropriate medications according to STOPP-Frail criteria in nursing home residents, the SHELTER study. BMC Geriatr 24:882. https:\/\/doi.org\/10.1186\/s12877-024-05450-y","journal-title":"BMC Geriatr"},{"key":"1269_CR27","doi-asserted-by":"publisher","first-page":"e290","DOI":"10.1016\/S2666-7568(21)00054-4","volume":"2","author":"PA Rochon","year":"2021","unstructured":"Rochon PA, Petrovic M, Cherubini A, Onder G, O\u2019Mahony D, Sternberg SA et al (2021) Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens. The Lancet Healthy Longevity 2:e290-300. https:\/\/doi.org\/10.1016\/S2666-7568(21)00054-4","journal-title":"The Lancet Healthy Longevity"},{"key":"1269_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jamda.2021.10.006","volume":"23","author":"WH Skretteberg","year":"2022","unstructured":"Skretteberg WH, Holmefoss I, Krogseth M (2022) Delirium during acute events in nursing home patients. J Am Med Dir Assoc 23:146\u2013149. https:\/\/doi.org\/10.1016\/j.jamda.2021.10.006","journal-title":"J Am Med Dir Assoc"},{"key":"1269_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12877-019-1028-z","volume":"19","author":"SE Lemoyne","year":"2019","unstructured":"Lemoyne SE, Herbots HH, De Blick D, Remmen R, Monsieurs KG, Van Bogaert P (2019) Appropriateness of transferring nursing home residents to emergency departments: a systematic review. BMC Geriatr 19:17. https:\/\/doi.org\/10.1186\/s12877-019-1028-z","journal-title":"BMC Geriatr"},{"key":"1269_CR30","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/ageing\/afu117","volume":"43","author":"R Dwyer","year":"2014","unstructured":"Dwyer R, Gabbe B, Stoelwinder JU, Lowthian J (2014) A systematic review of outcomes following emergency transfer to hospital for residents of aged care facilities. Age Ageing 43:759\u2013766. https:\/\/doi.org\/10.1093\/ageing\/afu117","journal-title":"Age Ageing"},{"key":"1269_CR31","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1177\/0269216319854944","volume":"33","author":"CL Watt","year":"2019","unstructured":"Watt CL, Momoli F, Ansari MT, Sikora L, Bush SH, Hosie A et al (2019) The incidence and prevalence of delirium across palliative care settings: a systematic review. Palliat Med 33:865\u2013877. https:\/\/doi.org\/10.1177\/0269216319854944","journal-title":"Palliat Med"},{"key":"1269_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jamda.2019.11.015","volume":"21","author":"JG Carpenter","year":"2020","unstructured":"Carpenter JG, Lam K, Ritter AZ, Ersek M (2020) A systematic review of nursing home palliative care interventions: characteristics and outcomes. J Am Med Dir Assoc 21:583-596.e2. https:\/\/doi.org\/10.1016\/j.jamda.2019.11.015","journal-title":"J Am Med Dir Assoc"},{"key":"1269_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/ageing\/afz171","volume":"49","author":"MR Agar","year":"2020","unstructured":"Agar MR (2020) Delirium at the end of life. Age Ageing 49:337\u2013340. https:\/\/doi.org\/10.1093\/ageing\/afz171","journal-title":"Age Ageing"},{"key":"1269_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/ageing\/aft166","volume":"43","author":"TJ Van Der Cammen","year":"2014","unstructured":"Van Der Cammen TJ, Rajkumar C, Onder G, Sterke CS, Petrovic M (2014) Drug cessation in complex older adults: time for action. Age Ageing 43:20\u201325. https:\/\/doi.org\/10.1093\/ageing\/aft166","journal-title":"Age Ageing"},{"key":"1269_CR35","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1365-2125.2009.03419.x","volume":"67","author":"D Fialov\u00e1","year":"2009","unstructured":"Fialov\u00e1 D, Onder G (2009) Medication errors in elderly people: contributing factors and future perspectives. Brit J Clinical Pharma 67:641\u2013645. https:\/\/doi.org\/10.1111\/j.1365-2125.2009.03419.x","journal-title":"Brit J Clinical Pharma"},{"key":"1269_CR36","unstructured":"Global Burden of Preventable Medication-Related Harm in Health Care: A Systematic Review. 1st ed. Geneva: World Health Organization; 2024."},{"key":"1269_CR37","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1471-2318-11-82","volume":"11","author":"A Szczepura","year":"2011","unstructured":"Szczepura A, Wild D, Nelson S (2011) Medication administration errors for older people in long-term residential care. BMC Geriatr 11:82. https:\/\/doi.org\/10.1186\/1471-2318-11-82","journal-title":"BMC Geriatr"},{"key":"1269_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12912-021-00587-2","volume":"20","author":"M Bengtsson","year":"2021","unstructured":"Bengtsson M, Ekedahl A-BI, Sj\u00f6str\u00f6m K (2021) Errors linked to medication management in nursing homes: an interview study. BMC Nurs 20:69. https:\/\/doi.org\/10.1186\/s12912-021-00587-2","journal-title":"BMC Nurs"},{"key":"1269_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/ageing\/afq140","volume":"40","author":"A Clegg","year":"2011","unstructured":"Clegg A, Young JB (2011) Which medications to avoid in people at risk of delirium: a systematic review. Age Ageing 40:23\u201329. https:\/\/doi.org\/10.1093\/ageing\/afq140","journal-title":"Age Ageing"},{"key":"1269_CR40","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","volume":"71","author":"MJ Samuel","year":"2023","unstructured":"Samuel MJ (2023) By the 2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc 71:2052\u20132081. https:\/\/doi.org\/10.1111\/jgs.18372","journal-title":"J Am Geriatr Soc"},{"key":"1269_CR41","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.49950","volume":"6","author":"CH Ormseth","year":"2023","unstructured":"Ormseth CH, LaHue SC, Oldham MA, Josephson SA, Whitaker E, Douglas VC (2023) Predisposing and precipitating factors associated with delirium: a systematic review. JAMA Netw Open 6:e2249950. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.49950","journal-title":"JAMA Netw Open"},{"key":"1269_CR42","doi-asserted-by":"publisher","first-page":"i32","DOI":"10.1093\/ijpp\/riad021.037","volume":"31","author":"K Clarke","year":"2023","unstructured":"Clarke K, Weedle P, Fleming A (2023) 491 Anticholinergic cognitive burden score in a cohort of nursing home patients; an observational study. Int J Pharm Pract 31:i32\u2013i32. https:\/\/doi.org\/10.1093\/ijpp\/riad021.037","journal-title":"Int J Pharm Pract"},{"key":"1269_CR43","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s40266-014-0227-8","volume":"32","author":"JB Palmer","year":"2015","unstructured":"Palmer JB, Albrecht JS, Park Y, Dutcher S, Rattinger GB, Simoni-Wastila L et al (2015) Use of drugs with anticholinergic properties among nursing home residents with dementia: a national analysis of medicare beneficiaries from 2007 to 2008. Drugs Aging 32:79\u201386. https:\/\/doi.org\/10.1007\/s40266-014-0227-8","journal-title":"Drugs Aging"},{"key":"1269_CR44","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s40266-018-0549-z","volume":"35","author":"TJ Welsh","year":"2018","unstructured":"Welsh TJ, van der Wardt V, Ojo G, Gordon AL, Gladman JRF (2018) Anticholinergic drug burden tools\/scales and adverse outcomes in different clinical settings: a systematic review of reviews. Drugs Aging 35:523\u2013538. https:\/\/doi.org\/10.1007\/s40266-018-0549-z","journal-title":"Drugs Aging"},{"key":"1269_CR45","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/j.jamda.2021.05.039","volume":"22","author":"L Oudewortel","year":"2021","unstructured":"Oudewortel L, van der Roest HG, Onder G, Wijnen VJM, Liperoti R, Denkinger M et al (2021) The association of anticholinergic drugs and delirium in nursing home patients with dementia: results from the SHELTER study. J Am Med Dir Assoc 22:2087\u20132092. https:\/\/doi.org\/10.1016\/j.jamda.2021.05.039","journal-title":"J Am Med Dir Assoc"},{"key":"1269_CR46","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jamda.2014.08.002","volume":"15","author":"F Landi","year":"2014","unstructured":"Landi F, Dell\u2019Aquila G, Collamati A, Martone AM, Zuliani G, Gasperini B et al (2014) Anticholinergic drug use and negative outcomes among the frail elderly population living in a nursing home. J Am Med Dir Assoc 15:825\u2013829. https:\/\/doi.org\/10.1016\/j.jamda.2014.08.002","journal-title":"J Am Med Dir Assoc"},{"key":"1269_CR47","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s40266-018-0612-9","volume":"36","author":"L Pasina","year":"2019","unstructured":"Pasina L, Colzani L, Cortesi L, Tettamanti M, Zambon A, Nobili A et al (2019) Relation between delirium and anticholinergic drug burden in a cohort of hospitalized older patients: an observational study. Drugs Aging 36:85\u201391. https:\/\/doi.org\/10.1007\/s40266-018-0612-9","journal-title":"Drugs Aging"},{"key":"1269_CR48","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2174\/1871530317666171120152048","volume":"18","author":"P Perez-Ros","year":"2018","unstructured":"Perez-Ros P, Martinez-Arnau FM, Baixauli-Alacreu S, Garcia-Gollarte JF, Tarazona-Santabalbina F (2018) A predictive model of the prevalence of delirium in elderly subjects admitted to nursing homes. Endocr Metab Immune Disord Drug Targets 18:355\u2013361. https:\/\/doi.org\/10.2174\/1871530317666171120152048","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"1269_CR49","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3233\/JAD-190391","volume":"70","author":"P P\u00e9rez-Ros","year":"2019","unstructured":"P\u00e9rez-Ros P, Mart\u00ednez-Arnau FM, Baixauli-Alacreu S, Caballero-P\u00e9rez M, Garc\u00eda-Gollarte JF, Tarazona-Santabalbina F (2019) Delirium predisposing and triggering factors in nursing home residents: a cohort trial-nested case-control study. J Alzheimers Dis 70:1113\u20131122. https:\/\/doi.org\/10.3233\/JAD-190391","journal-title":"J Alzheimers Dis"},{"key":"1269_CR50","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000322883","volume":"1","author":"MJ Luukkanen","year":"2011","unstructured":"Luukkanen MJ, Uusvaara J, Laurila JV, Strandberg TE, Raivio MM, Tilvis RS et al (2011) Anticholinergic drugs and their effects on delirium and mortality in the elderly. Dement Geriatr Cogn Dis Extra 1:43\u201350. https:\/\/doi.org\/10.1159\/000322883","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"1269_CR51","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1532-5415.2008.01680.x","volume":"56","author":"TE Lackner","year":"2008","unstructured":"Lackner TE, Wyman JF, McCarthy TC, Monigold M, Davey C (2008) Randomized, placebo-controlled trial of the cognitive effect, safety, and tolerability of oral extended-release oxybutynin in cognitively impaired nursing home residents with urge urinary incontinence. J Am Geriatr Soc 56:862\u2013870. https:\/\/doi.org\/10.1111\/j.1532-5415.2008.01680.x","journal-title":"J Am Geriatr Soc"},{"key":"1269_CR52","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.jagp.2015.07.004","volume":"23","author":"A Kolanowski","year":"2015","unstructured":"Kolanowski A, Mogle J, Fick DM, Campbell N, Hill N, Mulhall P et al (2015) Anticholinergic exposure during rehabilitation: cognitive and physical function outcomes in patients with delirium superimposed on dementia. Am J Geriatr Psychiatry 23:1250\u20131258. https:\/\/doi.org\/10.1016\/j.jagp.2015.07.004","journal-title":"Am J Geriatr Psychiatry"},{"key":"1269_CR53","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00228-013-1499-3","volume":"69","author":"CE Dur\u00e1n","year":"2013","unstructured":"Dur\u00e1n CE, Azermai M, Vander Stichele RH (2013) Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol 69:1485\u20131496. https:\/\/doi.org\/10.1007\/s00228-013-1499-3","journal-title":"Eur J Clin Pharmacol"},{"key":"1269_CR54","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jamda.2020.04.019","volume":"22","author":"A Egberts","year":"2021","unstructured":"Egberts A, Moreno-Gonzalez R, Alan H, Ziere G, Mattace-Raso FUS (2021) Anticholinergic drug burden and delirium: a systematic review. J Am Med Dir Assoc 22:65-73.e4. https:\/\/doi.org\/10.1016\/j.jamda.2020.04.019","journal-title":"J Am Med Dir Assoc"},{"key":"1269_CR55","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1017\/S1041610216001150","volume":"28","author":"SI Janus","year":"2016","unstructured":"Janus SI, van Manen JG, IJzerman MJ, Zuidema SU (2016) Psychotropic drug prescriptions in Western European nursing homes. Int Psychogeriatr 28:1775\u20131790. https:\/\/doi.org\/10.1017\/S1041610216001150","journal-title":"Int Psychogeriatr"},{"key":"1269_CR56","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S2215-0366(14)70263-9","volume":"1","author":"SK Inouye","year":"2014","unstructured":"Inouye SK, Marcantonio ER, Metzger ED (2014) Doing damage in delirium: the hazards of antipsychotic treatment in elderly people. The Lancet Psychiatry 1:312\u2013315. https:\/\/doi.org\/10.1016\/S2215-0366(14)70263-9","journal-title":"The Lancet Psychiatry"},{"key":"1269_CR57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12877-018-0733-3","volume":"18","author":"ENM Cheung","year":"2018","unstructured":"Cheung ENM, Benjamin S, Heckman G, Ho JM-W, Lee L, Sinha SK et al (2018) Clinical characteristics associated with the onset of delirium among long-term nursing home residents. BMC Geriatr 18:39. https:\/\/doi.org\/10.1186\/s12877-018-0733-3","journal-title":"BMC Geriatr"},{"key":"1269_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000490722","volume":"46","author":"V Morichi","year":"2018","unstructured":"Morichi V, Fedecostante M, Morandi A, Di Santo SG, Mazzone A, Mossello E et al (2018) A point prevalence study of delirium in italian nursing homes. Dement Geriatr Cogn Disord 46:27\u201341. https:\/\/doi.org\/10.1159\/000490722","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1269_CR59","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.trci.2017.02.003","volume":"3","author":"RM Carnahan","year":"2017","unstructured":"Carnahan RM, Brown GD, Letuchy EM, Rubenstein LM, Gryzlak BM, Smith M et al (2017) Impact of programs to reduce antipsychotic and anticholinergic use in nursing homes. Alzheimers Dement (N Y) 3:553\u2013561. https:\/\/doi.org\/10.1016\/j.trci.2017.02.003","journal-title":"Alzheimers Dement (N Y)"},{"key":"1269_CR60","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.archger.2011.06.011","volume":"55","author":"J Monette","year":"2012","unstructured":"Monette J, Alessa W, McCusker J, Cole M, Voyer P, Champoux N et al (2012) Association of resident and room characteristics with antipsychotic use in long-term care facilities (LTCF). Arch Gerontol Geriatr 55:66\u201369. https:\/\/doi.org\/10.1016\/j.archger.2011.06.011","journal-title":"Arch Gerontol Geriatr"},{"key":"1269_CR61","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1186\/s12877-021-02517-y","volume":"21","author":"K Sabbe","year":"2021","unstructured":"Sabbe K, Van Der Mast R, Dilles T, Van Rompaey B (2021) The prevalence of delirium in Belgian nursing homes: a cross-sectional evaluation. BMC Geriatr 21:634. https:\/\/doi.org\/10.1186\/s12877-021-02517-y","journal-title":"BMC Geriatr"},{"key":"1269_CR62","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/gps.2770","volume":"27","author":"M Boorsma","year":"2012","unstructured":"Boorsma M, Joling KJ, Frijters DHM, Ribbe ME, Nijpels G, Van Hout HPJ (2012) The prevalence, incidence and risk factors for delirium in Dutch nursing homes and residential care homes. Int J Geriat Psychiatr 27:709\u2013715. https:\/\/doi.org\/10.1002\/gps.2770","journal-title":"Int J Geriat Psychiatr"},{"key":"1269_CR63","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/00004714-199004000-00003","volume":"10","author":"SH Preskorn","year":"1990","unstructured":"Preskorn SH, Jerkovich GS (1990) Central nervous system toxicity of tricyclic antidepressants: phenomenology, course, risk factors, and role of therapeutic drug monitoring. J Clin Psychopharmacol 10:88\u201395. https:\/\/doi.org\/10.1097\/00004714-199004000-00003","journal-title":"J Clin Psychopharmacol"},{"key":"1269_CR64","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1186\/s12877-024-05022-0","volume":"24","author":"E-M Minoc","year":"2024","unstructured":"Minoc E-M, Villain C, Benbrika S, Chr\u00e9tien B, Descatoire P, Heraudeau M et al (2024) Association between antidepressant use and delirium in older adults: an analysis of the World Health Organization\u2019s global pharmacovigilance database. BMC Geriatr 24:600. https:\/\/doi.org\/10.1186\/s12877-024-05022-0","journal-title":"BMC Geriatr"},{"key":"1269_CR65","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1111\/jgs.18519","volume":"71","author":"S Liu","year":"2023","unstructured":"Liu S, Yuan Y, Baek J, Nunes AP, Pawasauskas J, Hume AL et al (2023) Comparative safety of adding serotonin and norepinephrine reuptake inhibitors ( SNRIs) versus nonsteroidal anti-inflammatory drugs ( NSAIDs) to short-acting opioids for non-malignant pain in nursing homes. J Am Geriatr Soc 71:3390\u20133402. https:\/\/doi.org\/10.1111\/jgs.18519","journal-title":"J Am Geriatr Soc"},{"key":"1269_CR66","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1186\/s12877-024-05360-z","volume":"24","author":"M Fedecostante","year":"2024","unstructured":"Fedecostante M, Balietti P, Di Santo SG, Zambon A, Marengoni A, Morandi A et al (2024) Delirium in nursing home residents: is there a role of antidepressants? A cross sectional study. BMC Geriatr 24:767. https:\/\/doi.org\/10.1186\/s12877-024-05360-z","journal-title":"BMC Geriatr"},{"key":"1269_CR67","doi-asserted-by":"publisher","first-page":"afaf074","DOI":"10.1093\/ageing\/afaf074","volume":"54","author":"GA Hughes","year":"2025","unstructured":"Hughes GA, Inacio MC, Rowett D, Caughey GE, Air T, Lang CE et al (2025) Risk of adverse outcomes associated with mirtazapine compared to sertraline use among older people living in long-term care facilities. Age Ageing 54:afaf074","journal-title":"Age Ageing"},{"key":"1269_CR68","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1111\/jgs.16751","volume":"68","author":"P Evrard","year":"2020","unstructured":"Evrard P, Henrard S, Foulon V, Spinewine A (2020) Benzodiazepine use and deprescribing in belgian nursing homes: results from the COME-ON study. J Am Geriatr Soc 68:2768\u20132777. https:\/\/doi.org\/10.1111\/jgs.16751","journal-title":"J Am Geriatr Soc"},{"key":"1269_CR69","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1017\/S1041610217002587","volume":"30","author":"J Bohlken","year":"2018","unstructured":"Bohlken J, Kostev K (2018) Prevalence and risk factors for delirium diagnosis in patients followed in general practices in Germany. Int Psychogeriatr 30:511\u2013518. https:\/\/doi.org\/10.1017\/S1041610217002587","journal-title":"Int Psychogeriatr"},{"key":"1269_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0311098","volume":"19","author":"L Kennedy","year":"2024","unstructured":"Kennedy L, Hirdes JP, Heckman G, Searle SD, McArthur C (2024) The effect of the COVID-19 pandemic on delirium incidence in Ontario long-term care homes: a retrospective cohort study. PLoS ONE 19:e0311098. https:\/\/doi.org\/10.1371\/journal.pone.0311098","journal-title":"PLoS ONE"},{"key":"1269_CR71","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1159\/000520975","volume":"50","author":"H Senderovich","year":"2021","unstructured":"Senderovich H, Gardner S, Berall A, Ganion M, Zhang D, Vinoraj D et al (2021) Benzodiazepine use and morbidity-mortality outcomes in a geriatric palliative care unit: a retrospective review. Dement Geriatr Cogn Disord 50:559\u2013567. https:\/\/doi.org\/10.1159\/000520975","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1269_CR72","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1001\/jama.1994.03520190064036","volume":"272","author":"ER Marcantonio","year":"1994","unstructured":"Marcantonio ER, Juarez G, Goldman L, Mangione CM, Ludwig LE, Lind L et al (1994) The relationship of postoperative delirium with psychoactive medications. JAMA 272:1518\u20131522","journal-title":"JAMA"},{"key":"1269_CR73","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2165\/00002512-199710050-00005","volume":"10","author":"BK Young","year":"1997","unstructured":"Young BK, Camicioli R, Ganzini L (1997) Neuropsychiatric adverse effects of antiparkinsonian drugs: characteristics. Evaluation Treatment Drugs Aging 10:367\u2013383. https:\/\/doi.org\/10.2165\/00002512-199710050-00005","journal-title":"Evaluation Treatment Drugs Aging"},{"key":"1269_CR74","doi-asserted-by":"publisher","first-page":"afae073","DOI":"10.1093\/ageing\/afae073","volume":"53","author":"N White","year":"2024","unstructured":"White N, Bazo-Alvarez JC, Koopmans M, West E, Sampson EL (2024) Understanding the association between pain and delirium in older hospital inpatients: systematic review and meta-analysis. Age Ageing 53:afae073","journal-title":"Age Ageing"},{"key":"1269_CR75","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.19417","author":"AP Nunes","year":"2025","unstructured":"Nunes AP, Jung H, Yuan Y, Baek J, Pawasauskas J, Hume AL et al (2025) Comparative safety of short-acting opioid dose escalation and long-acting opioid initiation in nursing home residents. J Am Geriatr Soc. https:\/\/doi.org\/10.1111\/jgs.19417","journal-title":"J Am Geriatr Soc"},{"key":"1269_CR76","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4140\/TCP.n.2017.285","volume":"32","author":"C Allen","year":"2017","unstructured":"Allen C, Zarowitz BJ, O\u2019Shea T, Datto C, Olufade T (2017) Clinical and functional characteristics of nursing facility residents with opioid-induced constipation. Consult Pharm 32:285\u2013298. https:\/\/doi.org\/10.4140\/TCP.n.2017.285","journal-title":"Consult Pharm"},{"key":"1269_CR77","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/gerona\/61.2.165","volume":"61","author":"A Won","year":"2006","unstructured":"Won A, Lapane KL, Vallow S, Schein J, Morris JN, Lipsitz LA (2006) Long-term effects of analgesics in a population of elderly nursing home residents with persistent nonmalignant pain. The J Gerontol: Series A 61:165\u2013169. https:\/\/doi.org\/10.1093\/gerona\/61.2.165","journal-title":"The J Gerontol: Series A"},{"key":"1269_CR78","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/gps.4468","volume":"32","author":"MG Cole","year":"2017","unstructured":"Cole MG, McCusker J, Wilchesky M, Voyer P, Monette J, Champoux N et al (2017) Use of medications that antagonize mediators of inflammatory responses may reduce the risk of delirium in older adults: a nested case-control study. Int J Geriatr Psychiatr 32:208\u2013213. https:\/\/doi.org\/10.1002\/gps.4468","journal-title":"Int J Geriatr Psychiatr"},{"key":"1269_CR79","first-page":"260","volume":"37","author":"JL Cole","year":"2020","unstructured":"Cole JL (2020) Steroid-induced sleep disturbance and delirium: a focused review for critically Ill patients. Fed Pract 37:260\u2013267","journal-title":"Fed Pract"},{"key":"1269_CR80","doi-asserted-by":"publisher","first-page":"6712","DOI":"10.1200\/JCO.2005.05.140","volume":"23","author":"J-D Gaudreau","year":"2005","unstructured":"Gaudreau J-D, Gagnon P, Harel F, Roy M-A, Tremblay A (2005) Psychoactive medications and risk of delirium in hospitalized cancer patients. JCO 23:6712\u20136718. https:\/\/doi.org\/10.1200\/JCO.2005.05.140","journal-title":"JCO"}],"container-title":["European Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-025-01269-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41999-025-01269-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-025-01269-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T04:28:21Z","timestamp":1766809701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41999-025-01269-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":80,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1269"],"URL":"https:\/\/doi.org\/10.1007\/s41999-025-01269-x","relation":{},"ISSN":["1878-7657"],"issn-type":[{"value":"1878-7657","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.  AC is Associate Editor for European Geriatric Medicine. He has not taken part in the review or selection process of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No ethical approval was required for this study, as it involved a review of existing published literature.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}